ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 2 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,487 | -10.9% | 9,295 | 0.0% | 0.00% | – |
| Q2 2023 | $266,581 | +25.7% | 9,295 | +5.1% | 0.00% | – |
| Q1 2023 | $212,087 | -4.9% | 8,848 | +6.8% | 0.00% | – |
| Q1 2022 | $223,000 | -27.4% | 8,282 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $307,000 | -22.7% | 8,282 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $397,000 | +41.3% | 8,301 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $281,000 | -22.4% | 8,301 | -5.2% | 0.00% | 0.0% |
| Q1 2021 | $362,000 | -11.7% | 8,758 | -7.2% | 0.00% | 0.0% |
| Q4 2020 | $410,000 | +24.2% | 9,440 | +22.6% | 0.00% | 0.0% |
| Q3 2020 | $330,000 | +57.1% | 7,702 | +71.2% | 0.00% | – |
| Q2 2020 | $210,000 | – | 4,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 46,819 | $2,031,000 | 0.47% |
| Orbimed Advisors | 1,206,886 | $49,844,000 | 0.47% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 25,000 | $1,033,000 | 0.40% |
| ARK Investment Management | 3,331,889 | $137,607,000 | 0.27% |
| FEDERATED HERMES, INC. | 3,203,000 | $132,284,000 | 0.26% |
| MGO ONE SEVEN LLC | 26,990 | $1,114,000 | 0.19% |
| Koss-Olinger Consulting, LLC | 20,000 | $826,000 | 0.14% |
| Jump Financial, LLC | 35,400 | $1,462,000 | 0.14% |
| Graham Capital Management, L.P. | 74,262 | $3,067,000 | 0.14% |
| New England Research & Management, Inc. | 6,005 | $248,000 | 0.14% |